GSK, Crick Institute Partner on Open R&D
The Drug Discovery and Development website reported that the Francis Crick Institute and GSK, the UK’s largest pharmaceutical company, are to partner on an open innovation collaboration exploring new avenues of medical research and drug discovery across a broad range of diseases. In the spirit of open innovation, research findings from the collaboration will be shared with the broader scientific community, via joint publication in peer-reviewed journals. This will enable important discoveries to be applied across the research community.
Click here to read the full article.